New Jersey A5270 mandates coverage for clinician-administered drugs without financial penalties or location restrictions.

New Jersey A5270 requires insurance carriers and pharmacy benefits managers to cover clinician-administered drugs without imposing additional financial penalties or certain limitations on the location of drug administration. The bill defines "clinician-administered drug" as a prescription drug or biologic that cannot be self-administered and is typically given by a health care provider in a clinical setting. It prohibits insurers from refusing to authorize, approve, or pay for these drugs, interfering with patient choice, or requiring drugs to be dispensed by a specific pharmacy.

New Jersey A5270 mandates coverage for clinician-administered drugs without financial penalties or location restrictions.

New Jersey A5270 requires insurance carriers and pharmacy benefits managers to cover clinician-administered drugs without imposing additional financial penalties or certain limitations on the location of drug administration. The bill defines "clinician-administered drug" as a prescription drug or biologic that cannot be self-administered and is typically given by a health care provider in a clinical setting. It prohibits insurers from refusing to authorize, approve, or pay for these drugs, interfering with patient choice, or requiring drugs to be dispensed by a specific pharmacy.